drugset / Trial / NCT01375946

Pharmacokinetic Study Of AGILE AG200-15 After Weekly Application Under Various Conditions in Healthy Female Volunteers

NCT01375946

Phase 1 Completed 24 enrolled Agile Therapeutics
NaSingle-groupOpen-labelBasic science

Summary

A study to evaluate pharmacokinetic profile, wearability and safety of AG200-15, transdermal delivery of levonorgestrel (LNG) and ethinyl estradiol (EE), under normal conditions and external conditions of heat, humidity, cold water and exercise.

Timeline

Start
2011-05
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule Other
Subject ethinyl estradiol Small molecule Other

Indications

No indication recorded.